These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6634473)

  • 21. Nervous release of vasoactive intestinal polypeptide from the feline uterus: pharmacological characteristics.
    Fahrenkrug J; Ottesen B
    J Physiol; 1982 Oct; 331():451-60. PubMed ID: 7153911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of action of vasoactive intestinal polypeptide on myometrial smooth muscle of rabbit and guinea-pig.
    Bolton TB; Lang RJ; Ottesen B
    J Physiol; 1981 Sep; 318():41-55. PubMed ID: 7320897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide Y-, substance P- and VIP-immunoreactive nerves in cat spleen in relation to autonomic vascular and volume control.
    Lundberg JM; Anggård A; Pernow J; Hökfelt T
    Cell Tissue Res; 1985; 239(1):9-18. PubMed ID: 2578317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for vasoactive intestinal polypeptide as a neurotransmitter in smooth muscle of the urogenital tract.
    Hunter JC; Maggio JE; Mantyh PW
    Brain Res; 1984 Jul; 305(2):221-9. PubMed ID: 6146387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasoactive intestinal polypeptide (VIP) in the male genitourinary tract: concentration and motor effect.
    Larsen JJ; Ottesen B; Fahrenkrug J; Fahrenkrug L
    Invest Urol; 1981 Nov; 19(3):211-3. PubMed ID: 7298295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the vasodilatory effects of vasoactive intestinal polypeptide (VIP) and peptide-HI (PHI) in the rabbit and the cat.
    Nilsson SF; Mäepea O
    Acta Physiol Scand; 1987 Jan; 129(1):17-26. PubMed ID: 3565040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of neuronal polypeptides on intestinal smooth muscle; a comparison with non-adrenergic, non-cholinergic nerve stimulation and ATP.
    Cocks T; Burnstock G
    Eur J Pharmacol; 1979 Mar; 54(3):251-9. PubMed ID: 428425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition by adrenergic neurone blocking agents of the relaxation induced by BRL 38227 in vascular, intestinal and uterine smooth muscle.
    Berry JL; Small RC; Hughes SJ; Smith RD; Miller AJ; Hollingsworth M; Edwards G; Weston AH
    Br J Pharmacol; 1992 Oct; 107(2):288-95. PubMed ID: 1422581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-synergistic relaxant effects of vasoactive intestinal polypeptide and SIN-1 in human isolated cavernous artery and corpus cavernosum.
    Hempelmann RG; Papadopoulos I; Herzig S
    Eur J Pharmacol; 1995 Apr; 276(3):277-80. PubMed ID: 7601214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropeptides in the human appendix. Distribution and motor effects.
    Ekblad E; Arnbjörnsson E; Ekman R; Håkanson R; Sundler F
    Dig Dis Sci; 1989 Aug; 34(8):1217-30. PubMed ID: 2473867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible role of bioactive peptides in the regulation of human detrusor smooth muscle - functional effects in vitro and immunohistochemical presence.
    Uckert S; Stief CG; Lietz B; Burmester M; Jonas U; Machtens SA
    World J Urol; 2002 Sep; 20(4):244-9. PubMed ID: 12215855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasoactive intestinal peptide as a neurotransmitter in the cerebral circulation.
    Duckles SP; Said SI
    Eur J Pharmacol; 1982 Mar; 78(3):371-4. PubMed ID: 6121712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of apamin on non-adrenergic, non-cholinergic vasodilator mechanisms in the intestines of the cat.
    Jodal M; Lundgren O; Sjöqvist A
    J Physiol; 1983 May; 338():207-19. PubMed ID: 6875956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experimental studies on VIP as non-cholinergic and non-adrenergic neurotransmitter in bladder neck and posterior urethra].
    Hosokawa H; Kaseda M
    Nihon Hinyokika Gakkai Zasshi; 1993 Mar; 84(3):440-9. PubMed ID: 8099983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased myometrial blood flow evoked by vasoactive intestinal polypeptide in the non-pregnant goat.
    Carter AM; Einer-Jensen N; Fahrenkrug J; Ottesen B
    J Physiol; 1981 Jan; 310():471-80. PubMed ID: 7230045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of various peptides on isolated rabbit lower esophageal sphincter.
    Kohjitani A; Shirakawa J; Okada S; Obara H
    Peptides; 1996; 17(6):927-31. PubMed ID: 8899810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contractile and dilatory action of neuropeptides on isolated human mesenteric blood vessels.
    Törnebrandt K; Nobin A; Owman C
    Peptides; 1987; 8(2):251-6. PubMed ID: 3588345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neural vasodilator control in the rectum of the cat and its possible mediation by vasoactive intestinal polypeptide.
    Andersson PO; Bloom SR; Edwards AV; Järhult J; Mellander S
    J Physiol; 1983 Nov; 344():49-67. PubMed ID: 6197521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of vasoactive intestinal polypeptide (VIP) on the in vitro and in vivo motility of the rabbit reproductive tract.
    Fredericks CM; Ashton SH
    Fertil Steril; 1982 Jun; 37(6):845-50. PubMed ID: 7084506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution and effects of pituitary adenylate cyclase activating peptide in cat and human lower oesophageal sphincter.
    Ny L; Larsson B; Alm P; Ekström P; Fahrenkrug J; Hannibal J; Andersson KE
    Br J Pharmacol; 1995 Dec; 116(7):2873-80. PubMed ID: 8680719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.